BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BSGCT - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bsgct.org
X-WR-CALDESC:Events for BSGCT
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260326T183000
DTEND;TZID=UTC:20260326T191500
DTSTAMP:20260430T011531
CREATED:20260223T180857Z
LAST-MODIFIED:20260224T090720Z
UID:10000009-1774549800-1774552500@bsgct.org
SUMMARY:Strategies for AAV capsid engineering
DESCRIPTION:AAV is a promising delivery vehicle for gene therapies with potential to be engineered for improved targeting\, higher potency and lower immunogenicity. However\, challenges also remain to improve their manufacturing and stability to achieve lower costs and ease of formulation and delivery.  Protein engineering provides a viable route to creating platform vectors ready-made for low cost manufacture and high dose formulation. Several protein engineering strategies will be presented for achieving this goal including guidance by bioinformatics\, physical structure calculations\, molecular dynamics simulations\, machine learning\, and generative-AI. New vector designs achieve improved stability\, transduction efficiency\, manufacturing production yield. \nSPEAKER \nProf Paul Dalby is Co-Director of the EPSRC Future Targeted Healthcare Manufacturing Hub\, and Deputy Head of the Department of Biochemical Engineering at UCL.  Paul’s research focuses on technologies to improve the design and formulation of therapeutic proteins and gene therapy vectors\, to improve their manufacture\, stability\, delivery and function.  He has pioneered smart directed evolution approaches that accelerate evolution in the lab. Recent work has used molecular dynamics simulations and computational protein design tools to guide stability and function modifying mutations into proteins and viral vectors. \nThe joining link will be sent to you upon registration. \n\n\n\n\nBSGCT PPE Talk –  Strategies for AAV capsid engineering\n\n\n\n\n\n\n\n\nYour details\n\n\n\n	Title\n		\n	\n	\n	\n	\n\n\n	Name\n		*\n	\n	\n	First\n	\n\n\n	Last Name\n		*\n	\n	\n	Last\n	\n\n\n	Email\n		*\n	\n	\n	\n	\n\n\n	Organisation\n		*\n	\n	\n	\n	\n\n\n	Position / role\n		*\n	\n	\n	\n	\n\n\n	BSGCT Membership Status\n		*\n	\n						\n					 Member\n					\n					 Non-member\n\n	\n	\n\n\n\n	\n\nSubmit\n\n\n\n		\n			\n			\n			\n				If you are human\, leave this field blank.			\n			\n		\n		\n\n\n\n\n\n\n 
URL:https://bsgct.org/event/strategies-for-aav-capsid-engineering/
CATEGORIES:Online Seminars,Patient and Public Engagement,Seminars
ATTACH;FMTTYPE=image/jpeg:https://bsgct.org/wp-content/uploads/2026/02/BSGCT-PostcardsYT-Thumbnails-SF.jpg
END:VEVENT
END:VCALENDAR